Live Analyst Rating Changes 1348 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Joanne Wuensch
Citi
Joanne Wuensch
Citi
Wall Street Analyst
★★★☆☆
#793
on 13Foresight · ranked by our own returns
52%
Success Rate
+5.5%
Average Return
15 of 29 calls profitable · +2.3% vs benchmark
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 52% of Joanne Wuensch's ratings turned a profit when each position was held for 1 year — averaging +5.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

160 Buy 86 Hold 9 Sell
Joanne's Stock Coverage 29 ratings · 2026-06-18
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
ABT
Abbott Laboratories
 Jun 17, 2026 BUY Strong Buy
+30.9% avg upside
35 analysts
$89.00
0.53% Upside
 +0.0%
EW
Edwards Lifesciences
 Jun 15, 2026 BUY Strong Buy
+12.1% avg upside
34 analysts
$101.00
16.47% Upside
 +0.0%
GKOS
Glaukos
 Jun 12, 2026 BUY Strong Buy
+7.8% avg upside
20 analysts
$162.00
27.08% Upside
 ·
MDT
Medtronic
 Jun 03, 2026 BUY Buy
+24.8% avg upside
38 analysts
$110.00
40.68% Upside
 +3.1%
MMED
MiniMed Group, Inc.
 Jun 03, 2026 BUY Strong Buy
+52.3% avg upside
13 analysts
$23.00
62.39% Upside
 ·
HAE
Haemonetics
 May 29, 2026 HOLD Buy
-8.0% avg upside
17 analysts
$70.00
3.81% Downside
 ·
BSX
Boston Scientific
 May 29, 2026 BUY Strong Buy
+73.6% avg upside
38 analysts
$70.00
55.79% Upside
 -6.2%
DXCM
Dexcom
 May 29, 2026 BUY Strong Buy
+40.0% avg upside
32 analysts
$84.00
17.85% Upside
 -0.8%
BAX
Baxter International
 May 29, 2026 HOLD Hold
+51.7% avg upside
23 analysts
$17.00
12.38% Downside
 +10.8%
ITGR
Integer Holdings
 May 29, 2026 HOLD Buy
+7.4% avg upside
15 analysts
$92.00
2.83% Upside
 +1.2%
SGHT
Sight Sciences
 May 29, 2026 HOLD Buy
+59.2% avg upside
13 analysts
$5.15
2.88% Upside
 ·
TNDM
Tandem Diabetes Care
 May 29, 2026 HOLD Buy
+113.0% avg upside
29 analysts
$17.00
10.34% Upside
 -1.7%
ZBH
Zimmer Biomet Holdings
 May 29, 2026 HOLD Buy
+28.0% avg upside
37 analysts
$93.00
6.74% Upside
 +7.8%
PODD
Insulet
 May 29, 2026 HOLD Strong Buy
+81.1% avg upside
32 analysts
$165.00
14.93% Upside
 +3.3%
SYK
Stryker
 May 28, 2026 BUY Strong Buy
+25.2% avg upside
36 analysts
$385.00
27.77% Upside
 -1.3%
COO
Cooper Co
 May 28, 2026 HOLD Buy
+104.4% avg upside
21 analysts
$69.00
6.06% Upside
 +10.3%
IART
Integra Lifesciences
 May 28, 2026 HOLD Buy
+139.2% avg upside
21 analysts
$16.00
7.06% Downside
 +6.9%
ISRG
Intuitive Surgical
 May 28, 2026 BUY Strong Buy
+30.4% avg upside
36 analysts
$590.00
46.74% Upside
 -1.6%
PEN
Penumbra
 May 07, 2026 HOLD Buy
+4.7% avg upside
23 analysts
$350.00
10.69% Upside
 -2.2%
ESTA
Establishment Labs Holdings
 May 06, 2026 HOLD Strong Buy
+0.0% avg upside
12 analysts
$76.00
7.81% Downside
 +10.8%
IRTC
Irhythm Technologies
 May 04, 2026 BUY Strong Buy
+64.7% avg upside
19 analysts
$157.00
54.34% Upside
 ·
GEHC
GE Healthcare Technologies Inc
 Apr 30, 2026 HOLD Strong Buy
+36.4% avg upside
20 analysts
$65.00
6.32% Upside
 +7.1%
BLCO
Bausch + Lomb Corporation
 Apr 30, 2026 BUY Buy
+30.6% avg upside
19 analysts
$19.00
27.95% Upside
 -4.5%
JNJ
Johnson & Johnson
 Apr 26, 2026 BUY Strong Buy
-5.3% avg upside
36 analysts
$285.00
21.77% Upside
 +5.0%
BDX
Becton Dickinson
 Apr 07, 2026 BUY Buy
+37.4% avg upside
25 analysts
$198.00
39.72% Upside
 -5.0%
LUNG
Pulmonx
 May 23, 2025 HOLD Buy
+323.8% avg upside
9 analysts
$4.15
232.09% Upside
 -50.2%
CH:ALC
Alcon
 Nov 16, 2022 HOLD Buy
+37.6% avg upside
32 analysts
$55.09
6.56% Upside
 ·
RMD
Resmed
 Jan 27, 2019 BUY Buy
+26.6% avg upside
27 analysts
$120.00
35.66% Downside
 +77.7%
PFE
Pfizer
 Sep 26, 2016 BUY Buy
+31.6% avg upside
45 analysts
$40.00
54.25% Upside
 +9.2%
🔒 24 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Joanne Wuensch — Frequently Asked Questions
How accurate are Joanne Wuensch's stock ratings?
Based on the calls 13Foresight could measure, about 52% of Joanne's ratings were profitable over a one-year hold, with an average return of +5.5% per rating, or +2.3% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Joanne ranked on 13Foresight?
Joanne Wuensch is currently ranked #793 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Joanne cover?
Joanne most recently has ratings on ABT, EW, GKOS, MDT, MMED, HAE, BSX, DXCM, BAX, ITGR, SGHT, TNDM and 17 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.